In this study, we demonstrated that Fn can mediate attachment of M. tuberculosis to murine AMs. The data suggest that Fn interacts with M. tuberculosis via the heparin binding domain (HBD) of Fn. Fn-enhanced attachment of M. tuberculosis to murine AMs was decreased by the addition of monoclonal antibodies (MAbs) to either HBD or cell binding domain. Further, Fn-mediated attachment of M. tuberculosis to AMs was blocked by the tetrapeptide sequence of the CBD, RGDS (Arg-Gly-Glu-Ser), suggesting a possible role for the CBD of Fn in the mediation of Fn attachment to AMs.
Tuberculosis remains a major health problem throughout the world (11, 38) . The initial infection with Mycobacterium tuberculosis typically occurs in the alveolar spaces of the lung. Attachment of the tubercle bacillus to alveolar macrophages (AMs) is a crucial step in the establishment of infection, as the organism first survives and replicates in AMs as an intracellular pathogen. Previous studies have shown that M. tuberculosis organisms can attach and enter macrophages by specific cell surface receptors, including complement receptors (CR1 and CR3), the C2a component of complement, mannose receptor, transferrin receptor, CD14 scavenger receptor, and an unknown receptor that is inhibited by ␤-glucan (12, 40) .
Fibronectin (Fn) is known to mediate attachment of several different microorganisms to host cells (17) . Fn is an extracellular matrix protein with two similar subunits joined near the C-terminal end. This heterodimeric glycoprotein contains multiple binding domains and possesses binding properties to different ligands such as heparin, collagen, and fibrin (52) . Fn binds to a wide variety of microorganisms in a ligand receptormediated manner (17) . For instance, previous in vitro studies have shown that Fn binds to Escherichia coli, Streptococcus pyogenes, Salmonella enterica serovar Dublin, and Candida albicans (6, 14, 33, 39) . The binding sites of Fn play an integral role in the recognition of microorganisms. For example, Fn binds Staphylococcus aureus via the N-terminal domain and Treponema pallidum via the cell binding domain (CBD) of Fn (36, 47) . Similarly, in vitro, Fn facilitates the attachment of Pneumocystis carinii to AMs via the CBD (34) that is known to interact with integrins on the cell surface. Other studies indicate that microbial attachment may occur through different binding sites on Fn, such as the C-terminal domain (24, 45, 51) .
Prior studies have shown that mycobacteria interact with Fn. Fn attachment proteins (FAP) are surface proteins that are present in a variety of mycobacterial species, including Mycobacterium tuberculosis (1) , Mycobacterium avium (43) , Mycobacterium leprae (44) , and Mycobacterium vaccae (37) . The FAP are a family of highly homologous proteins (37) . The FAP from M. leprae bound to the carboxy-terminal heparin binding chymotryptic fragment of Fn (44) . Antibodies directed against FAP significantly inhibit attachment of mycobacteria to host epithelial cells (23) . Additionally, M. tuberculosis secrete an Fn-binding protein known as the antigen 85 complex (49) . This complex is composed of three proteins, Ag85A, Ag85B, and Ag85C. The antigen 85 functions as a mycolyl transferase (3). Disruption of the gene for Ag85A results in diminished growth of M. tuberculosis in cultured macrophages (2) .
In this study, we demonstrated that Fn can mediate attachment of M. tuberculosis to murine AMs. The data suggest that Fn interacts with M. tuberculosis via the heparin binding domain (HBD) of Fn. Fn-enhanced attachment of M. tuberculosis to murine AMs was decreased by the addition of monoclonal antibodies (MAbs) to either HBD or cell binding domain. Further, Fn-mediated attachment of M. tuberculosis to AMs was blocked by the tetrapeptide sequence of the CBD, RGDS (Arg-Gly-Glu-Ser), suggesting a possible role for the CBD of Fn in the mediation of Fn attachment to AMs.
MATERIALS AND METHODS
M. tuberculosis isolation. The H37Ra strain of M. tuberculosis (American Type Culture Collection, Manassas, Va.) was cultured at 37°C in 5% CO 2 atmosphere in dispersed form in Middlebrook 7H9 broth (Difco Laboratories, Detroit, Mich.) containing albumin, dextrose, and catalase as enrichments. Bacterial growth was monitored by a Spectronic 20D spectrophotometer (Milton Roy Company, Rochester, N.Y.) (9) . To achieve a single-cell suspension, the bacterial suspension was briefly sonicated (20 W for 5 to 10 s). The suspension was then gently agitated and allowed to settle for 5 min. The top portion of the suspension containing bacteria was used in the assay. Bacterial cultures, 10 to 14 days old, were centrifuged and washed once with normal saline. The final concentration of the bacterial suspension was adjusted to 10 9 organisms/ml. Each batch of bacterial suspension was stained with Kinyoun stain (Midlantic Biomedical Inc., Paulsboro, N.J.) and observed under the microscope to verify the purity of the suspension. Routinely, samples of bacteria were also grown on mycobacterial 7H11 agar (Difco Laboratories) plates as stock.
Isolation and preparation of Fn. Bovine Fn was used for the majority of studies due to its homology with human Fn and because it shares identical binding sites with human Fn (18, 21) . Bovine Fn was much less expensive than human Fn and was isolated according to the method of Hynes (19) with modifications (50) . Briefly, a gelatin-Sepharose column 125 I-Fn and M. tuberculosis organisms were incubated with anti-Fn MAbs for 60 min. After the incubation, the samples were washed by centrifugation in DMEM to remove free 125 I-Fn and unbound antibody. The fractions were counted in a gamma counter to determine the amount of bound 125 I-Fn. AM isolation. Murine AMs were isolated by bronchoalveolar lavage from 10-week-old Swiss Webster pathogen-free mice (Harlan Sprague-Dawley, Inc. Indianapolis, Ind.) as previously described (10) . Briefly, the mice were sacrificed by intraperitoneal injection of Beuthanasia-D solution (Schering-Plough Animal Health Corporation, Kenilworth, N.J.). The trachea was cannulated following a midline neck incision, and the lungs were lavaged 10 times with 1.0 ml of 0.9% sodium chloride solution containing 0.6 mM EDTA, penicillin (100 U/ml), streptomycin (100 g/ml), gentamicin (40 g/ml), and amphotericin B (0.5 g/ml). Approximately 7 to 8 ml of lavage fluid was obtained from each mouse. AMs were separated from the lavage fluid by centrifugation at 600 ϫ g for 10 min. Red blood cells were lysed with 10 mM KHCO 3 and 152 mM NH 4 Cl. Cells were washed three times with normal saline and resuspended in DMEM (BioWhittaker, Inc., Walkersville, Md.) with 10% heat-inactivated fetal bovine serum, glutamine (300 g/ml), penicillin (100 U/ml), and 20 mM HEPES (pH 7.2). Cell preparations were demonstrated to be 98% pure AMs by routine Hema 3 staining, a Giemsa-like staining method (Biochemical Sciences, Inc., Bridgeport, N.J.), and to be greater than 95% viable by trypan blue exclusion. AMs were plated at a density of 2.5 ϫ 10 5 /100 l/well on rat immunoglobulin G (IgG) (Calbiochem, San Diego, Calif.)-coated 96-well tissue culture plates, incubated for 24 h at 37°C in 5% CO 2 , and washed three times with antibiotic-free DMEM (200 l/well) to remove unattached cells. The plates were stored at 4°C for 1 h prior to the attachment assay.
M. tuberculosis attachment assay. Attachment of M. tuberculosis organisms to AMs was determined as described previously by our laboratory (10) . Briefly, freshly isolated M. tuberculosis organisms were incubated for 18 h in 1 ml of serum-free DMEM and 200 Ci of sodium chromate [
51 Cr] (New England Nuclear, Boston, Mass.). The 51 Cr-labeled M. tuberculosis organisms were centrifuged (3,800 ϫ g, 15 min), the supernatant was discarded, and the pellet was washed four times to remove unincorporated 51 Cr. A final concentration of 2.5 ϫ 10 5 51 Cr-labeled M. tuberculosis organisms in 100 l of DMEM was added to each well of a 96-well tissue culture plate containing adherent AMs. After the incubation at 4°C, unbound organisms were removed by washing the monolayer cells three times with 200 l of DMEM. The washes from each well were pooled and centrifuged at 3,000 ϫ g for 30 min to separate unattached M. tuberculosis organisms from the supernatant. The supernatant was transferred to a separate tube. The adherent AMs in the 96-well plate containing bound M. tuberculosis were solubilized by the addition of 200 l of 10% Triton X-100 (Sigma Chemical Co.). The radioactivity in each fraction was measured in a gamma counter, and percent attachment was expressed as follows: % attachment ϭ (A/A ϩ B) ϫ 100, where A is 51 Cr-labeled M. tuberculosis organisms bound to the AMs and B is unattached 51 Cr-labeled M. tuberculosis organisms free in the medium. To determine percent injury to M. tuberculosis organisms, the percent release is expressed as follows: % release ϭ (A/(A ϩ B ϩ C) ϫ 100, where B is the number of counts per minute from 51 Cr-labeled M. tuberculosis organisms bound to the AMs, A is the number of counts per minute from 51 Cr-released into the medium, and C is the number of counts per minute from unattached 51 Cr-labeled M. tuberculosis organisms free in the medium.
To determine the possible mechanisms involved in Fn-mediated attachment, 51 Cr-labeled M. tuberculosis organisms were added to each well and incubated with the AMs at 4°C for 4 h. At 4°C only attachment (no phagocytosis) occurs. The attachment assay was performed to examine the effect of heparin (1.0 mM; Sigma Chemical Co.), RGDS (1.0 mM), RGES (1.0 mM), polyclonal antibodies to human Fn (100 g/ml), and MAbs to human Fn (100 g/ml; Chemicon, International) and in the presence or absence of appropriate isotype control MAbs (Chemicon, International) on M. tuberculosis attachment to AMs.
Statistical analysis. A minimum of three experiments conducted in triplicate were performed. The results are expressed as means Ϯ standard errors of the means (SEM). For each experiment the differences between control and experimental data were compared using Student's t test or analysis of variance with paired comparisons. Data were accepted as significantly different if P was Ͻ0.05 (22) .
RESULTS

I-Fn binding to M. tuberculosis.
125 I-Fn binding to M. tuberculosis was time dependent, and this binding was saturated after 60 min (24.0 Ϯ 2.5 ng). Fn binding was also concentration dependent, and saturation of binding was observed at or above Fn concentrations of 10 g/ml. Further, 125 I-Fn binding to M. tuberculosis was calcium concentration dependent, with saturation of binding occurring at or above 2 mM Ca 2ϩ (51.3 Ϯ 2.3 ng). These results indicate that 125 I-Fn binds to M. tuberculosis in time-, Fn concentration-, and Ca 2ϩ concentration-dependent manners.
To determine the binding mechanism, 125 I-Fn and M. tuberculosis organisms were incubated in the presence or absence of Fn peptide (RGDS), heparin, and various MAbs directed against different sites on Fn (Fig. 1 ). Heparin and a MAb specific to the HBD of Fn significantly decreased Fn binding to M. tuberculosis organisms from 51.3 Ϯ 2.3 ng to 30.9 Ϯ 2.4 ng and to 21.9 Ϯ 1.5 ng, respectively (P Ͻ 0.05) (Fig. 1) . However (Fig. 2a) . In the presence of Fn, attachment increased in a concentration-dependent manner (Fig. 2b) , with maximal binding at approximately 10 g/ml (33.5% Ϯ 3.4%). The binding pattern of M. tuberculosis to AMs in the presence of Fn appears to be second order. There was no significant killing of M. tuberculosis as a result of Fn-mediated attachment to AMs, as measured by 51 Cr release from M. tuberculosis (data not shown). Therefore, an Fn concentration of 10 g/ml was used for all subsequent experiments.
The specificity of Fn-enhanced attachment of M. tuberculosis to AMs was examined in the presence of Fn and polyclonal antibodies to Fn. Addition of anti-Fn polyclonal antibodies to the attachment assay significantly decreased the Fn-enhanced attachment from 44.2% Ϯ 4.2% to 10.8% Ϯ 1.2% (P Ͻ 0.05) (Fig. 3) spectively, whereas MAb specific to GBD showed no significant effect on M. tuberculosis attachment to AMs (40.5% Ϯ 1.8% [P Ͼ 0.05]) (Fig. 3) . Thus, these results suggest that Fn-enhanced attachment of M. tuberculosis to AMs is mediated, in part, by the HBD of the Fn molecule recognizing M. tuberculosis and the CBD of Fn recognizing a surface receptor on AMs (27) . Attachment of M. tuberculosis to AMs was significantly decreased in the presence of heparin from 44.2% Ϯ 4.2% to 11.8% Ϯ 1.1% (P Ͻ 0.05) and in the presence of RGDS peptide to 15.3% Ϯ 1.2% (P Ͻ 0.05) (Fig. 4) . However, the false binding peptide, RGES, had no significant effect (40.5% Ϯ 1.8% [P Ͼ 0.05]) on M. tuberculosis attachment to AMs (Fig.  4) . Taken together, these data suggest that Fn may act as a bridge between the microorganisms and the AMs. These data suggest that the HBD of Fn binds to M. tuberculosis, whereas the CBD of Fn binds to the AMs.
DISCUSSION
This study suggests that Fn binds to M. tuberculosis and that Fn can mediate attachment of M. tuberculosis to murine AMs. A MAb specific to the HBD of Fn, but not to the CBD or GBD of Fn, decreased binding of Fn to M. tuberculosis, suggesting that the HBD is the site on the Fn molecule responsible for Fn binding to M. tuberculosis. Fn-enhanced attachment of M. tuberculosis to murine AMs was decreased by the addition of MAbs specific to either the HBD or CBD or by RGDS, suggesting that the CBD of Fn likely plays a role in the Fnmediated attachment of M. tuberculosis to AMs. Therefore, Fn may act as a bridge between M. tuberculosis and the AM. As Fn is a constitutively expressed protein in the lung (7) and is increased during inflammation (16) , this interaction may represent a normal host response in the initial week of new infection in the alveolar spaces.
Fn is a large adhesive matrix protein with multiple binding domains known to mediate the adherence of many pathogenic microorganisms in a ligand receptor-mediated manner (17) . Examples include E. coli, S. pyogenes, S. enterica serovar Dublin, C. albicans, S. aureus, T. pallidum, and P. carinii (14, 33, 35, 36, 39, 46, 47) . For instance, previous studies from our laboratory have shown that P. carinii binds to Fn via the RGDS binding sites of Fn, and Fn appears to mediate the attachment of P. carinii to AMs with the RGDS binding site on the other arm of Fn molecule (34) . As AMs are important in clearance of this extracellular pathogen from alveolar spaces (26) bacteria interacts with either the C-terminal HBD or the more central CBD (29) . In contrast, other studies have shown that gelatin but not heparin inhibited the binding of Fn to 85B protein (32 (20) . Fn-mediated interactions may involve different sites on the Fn molecule. Our study shows Fn can increase attachment of M. tuberculosis to AMs; however, increased attachment does not necessarily mean there is an increase in phagocytosis by AMs (14) .
In all likelihood M. tuberculosis attachment and phagocytosis are multifactoral, involving multiple mechanisms and receptors (12, 40) . M. tuberculosis organisms have developed a number of mechanisms to gain entry into the macrophages using specific cell surface receptors (12) . Like other microorganisms, M. tuberculosis binds to CR1, CR3, and CR4, which in turn results in the phagocytosis of the bacilli and entry into the phagosomes (42) . M. tuberculosis can enter macrophages through the mannose receptors (41) . Surfactant apoproteins such as surfactant protein A (SP-A) or SP-D may also facilitate attachment and/or phagocytosis of M. tuberculosis to macrophages (13) . Our study clearly demonstrates that Fn enhances attachment of M. tuberculosis to AMs. The lung is a rich source of Fn, and Fn production increases in response to infection or inflammation (7) . Multiple studies suggest that Fn plays a role in recognition of various species of mycobacteria. No studies have yet delineated which of these several mechanisms predominate in vivo. Because mycobacteria are intracellular pathogens, some mechanisms of attachment may enhance infection, whereas others may facilitate clearance of mycobacteria (4, 8, 31) .
In summary, these Fn binding studies suggest that Fn binds to the M. tuberculosis organisms, likely through its HBD, whereas Fn-mediated binding of M. tuberculosis to the AM likely occurs through the CBD of the Fn molecule. Thus, Fn may promote the attachment of M. tuberculosis to AMs by acting as a bridge between the organism and the host cell. Further insights into the mechanisms of M. tuberculosis attachment to AMs may provide important information in the pathogenesis of this disease and may permit the development of therapeutic strategies to modulate this infectious process.
